Related Experiment Video
Updated: Apr 7, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Demographic Studies from a National Gaucher Disease Screening Program.
D M Gagnon1, E Pergament, B A Fine
1, .
A nationwide screening program identified 3.4% of participants with Gaucher disease. Common symptoms included fatigue, bone pain, and bruising, highlighting the need for increased disease recognition.
Area of Science:
- Genetics and Genetic Diseases
- Rare Diseases
- Metabolic Disorders
Background:
- Gaucher disease is a rare genetic disorder.
- Early diagnosis and recognition are crucial for management.
- A nationwide screening program was established to address these needs.
Purpose of the Study:
- To assess the effectiveness of a self-selected screening program for Gaucher disease.
- To identify individuals with undiagnosed Gaucher disease.
- To analyze reported symptoms and risk factors.
Main Methods:
- A self-report screening form collected data from 700 individuals on symptoms, age, ancestry, gender, and family history.
- Individuals designated "high risk" were offered beta-glucocerebrosidase enzyme assay testing.
- Statistical analysis compared symptom reporting between high-risk and low-risk groups.
Main Results:
- Gaucher disease was diagnosed in 3.4% (24/700) of respondents.
- The most frequent symptoms reported were fatigue, bone pain, and bruising.
- Liver enlargement and unexplained bone fractures were statistically significant indicators of high risk.
Conclusions:
- The screening program successfully identified individuals with Gaucher disease.
- Symptom reporting can aid in identifying individuals at high risk.
- Further research is needed to understand symptomatology in affected versus unaffected individuals.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...